Table 2.
Prevalence of OIs or HIV-associated malignancies among WLHIV in Ethiopia (2007–2019).
| Year | Oral candidiasis | Herpes zoster | PCP | Toxoplasmosis | TB | Cervical cancer | Lymphoma | |||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| % | Incidence | % | Incidence | % | Incidence | % | Incidence | % | Incidence | % | Incidence | % | Incidence | |
| 2007 | 28 | 0.02 | 21.7 | 0.015 | 9.5 | 0.007 | 3.9 | 0.005 | 20.1 | 0.012 | 13.5 | 0.01 | 27.6 | 0.018 |
| 2008 | 22.8 | 0.035 | 16.3 | 0.026 | 0.7 | 0.007 | 3.8 | 0.007 | 18.3 | 0.025 | 9 | 0.017 | 21.8 | 0.034 |
| 2009 | 16.7 | 0.046 | 11.5 | 0.034 | 2.4 | 0.009 | 2.4 | 0.009 | 17.4 | 0.036 | 10.5 | 0.025 | 12.5 | 0.042 |
| 2010 | 14.7 | 0.055 | 9.8 | 0.04 | 3 | 0.011 | 1.5 | 0.009 | 15.4 | 0.044 | 9.8 | 0.032 | 9.8 | 0.047 |
| 2011 | 13.3 | 0.065 | 8.1 | 0.047 | 3.2 | 0.013 | 1.1 | 0.01 | 14.7 | 0.056 | 11.2 | 0.04 | 14.4 | 0.058 |
| 2012 | 8.9 | 0.077 | 7.9 | 0.057 | 0.6 | 0.014 | 0.4 | 0.01 | 3.5 | 0.059 | 11.2 | 0.055 | 6.8 | 0.066 |
| 2013 | 14.8 | 0.1 | 7.7 | 0.07 | 1.8 | 0.016 | 1.8 | 0.013 | 11 | 0.074 | 11.5 | 0.075 | 8.1 | 0.079 |
| 2014 | 12.3 | 0.11 | 2.7 | 0.073 | 1.4 | 0.017 | 1.9 | 0.014 | 3 | 0.076 | 14.5 | 0.091 | 5.2 | 0.085 |
| 2015 | 2.7 | 0.111 | 5 | 0.076 | 2.7 | 0.018 | 2.3 | 0.015 | 1.8 | 0.078 | 13.6 | 0.099 | 10 | 0.09 |
| 2016 | 7.1 | 0.113 | 3.9 | 0.076 | 2.4 | 0.018 | 1.6 | 0.015 | 10.2 | 0.08 | 14.1 | 0.103 | 8.6 | 0.091 |
| 2017 | 27 | 0.123 | 26.2 | 0.086 | 5.7 | 0.021 | 2.5 | 0.016 | 30.3 | 0.089 | 14.8 | 0.108 | 23 | 0.099 |
| 2018 | 34.7 | 0.138 | 12.8 | 0.093 | 5.1 | 0.023 | 4.6 | 0.017 | 27 | 0.102 | 11.7 | 0.113 | 25.5 | 0.113 |
| 2019 | 12.2 | 0.141 | 24.4 | 0.1 | 3.3 | 0.024 | 2.2 | 0.018 | 38.9 | 0.109 | 11.1 | 0.115 | 33.3 | 0.119 |
| Overall | 16.5 | 0.087 | 12.1 | 0.061 | 3.2 | 0.01 | 2.30 | 0.012 | 16.2 | 0.065 | 12.0 | 0.068 | 15.8 | 0.072 |